Bionano Genomics (MEX:BNGO) Research & Development : MXN452.8 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Bionano Genomics Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Bionano Genomics's Research & Development for the three months ended in Dec. 2024 was MXN72.5 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was MXN452.8 Mil.

Bionano Genomics Research & Development Historical Data

The historical data trend for Bionano Genomics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionano Genomics Research & Development Chart

Bionano Genomics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Research & Development

Get a 7-Day Free Trial

204.01

461.26

956.22

917.15

517.28

Bionano Genomics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Research & Development	Get a 7-Day Free Trial															198.62	162.30	125.15	92.88	72.45

Bionano Genomics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN452.8 Mil.

Bionano Genomics (MEX:BNGO) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Bionano Genomics Research & Development Related Terms

Thank you for viewing the detailed overview of Bionano Genomics's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Bionano Genomics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bionano Genomics Inc (MEX:BNGO) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

BNGO:USA 0A4K:UK

Address

9540 Towne Centre Drive, Suite 100, San Diego, CA, USA, 92121

Website

https://www.bionano.com

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.